Cite

HARVARD Citation

    Sands, B. et al. (n.d.). OC-045 Efficacy & safety of dose adjustment & delayed response to ustekinumab in moderate–severe crohn's disease patients: results from im-uniti maintenance study. Gut. p. A23. [Online]. 
  
Back to record